{"cannot_find_item": [], "decode_error": [], "polarity_error": [{"polarity": ["false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "phenytoin", "drug2": "phenytoin"}, {"polarity": ["false", "false", "false", "false", "false", "false", "false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "methotrexate", "drug2": "phenytoin"}, {"polarity": ["false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "methotrexate", "drug2": "methotrexate"}, {"polarity": ["false", "false", "false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "warfarin", "drug2": "phenytoin"}, {"polarity": ["false", "false", "false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "warfarin", "drug2": "methotrexate"}, {"polarity": ["false", "false", "false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "sulfonylurea agents", "drug2": "phenytoin"}, {"polarity": ["false", "false", "false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "sulfonylurea agents", "drug2": "methotrexate"}, {"polarity": ["false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "sulfonylurea agents", "drug2": "warfarin"}, {"polarity": ["false", "false", "false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "cyclosporine", "drug2": "phenytoin"}, {"polarity": ["false", "false", "false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "cyclosporine", "drug2": "methotrexate"}, {"polarity": ["false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "cyclosporine", "drug2": "warfarin"}, {"polarity": ["false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "cyclosporine", "drug2": "sulfonylurea agents"}, {"polarity": ["false", "false", "false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "thiazides", "drug2": "phenytoin"}, {"polarity": ["false", "false", "false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "thiazides", "drug2": "methotrexate"}, {"polarity": ["false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "thiazides", "drug2": "warfarin"}, {"polarity": ["false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "thiazides", "drug2": "sulfonylurea agents"}, {"polarity": ["false", "false"], "orig_sen": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "drug1": "thiazides", "drug2": "cyclosporine"}, {"polarity": ["effect", "effect"], "orig_sen": "The pressor response of adrenergic agents may also be potentiated by tricyclic antidepressants.", "drug1": "adrenergic agents", "drug2": "tricyclic antidepressants"}, {"polarity": ["effect", "effect"], "orig_sen": "Vasopressors, particularly metaraminol, may cause serious cardiac arrhythmias during halothane anesthesia and therefore should be used only with great caution or not at all. ", "drug1": "metaraminol", "drug2": "halothane"}, {"polarity": ["effect", "effect"], "orig_sen": "Vasopressors, particularly metaraminol, may cause serious cardiac arrhythmias during halothane anesthesia and therefore should be used only with great caution or not at all. ", "drug1": "Vasopressors", "drug2": "halothane"}, {"polarity": ["false", "false"], "orig_sen": "Vasopressors, particularly metaraminol, may cause serious cardiac arrhythmias during halothane anesthesia and therefore should be used only with great caution or not at all. ", "drug1": "Vasopressors", "drug2": "metaraminol"}, {"polarity": ["false", "false"], "orig_sen": "Phenobarbital, which induces hepatic metabolism, decreased the AUC of montelukast approximately 40% following a single 10-mg dose of montelukast. ", "drug1": "montelukast", "drug2": "montelukast"}, {"polarity": ["false", "false", "false", "false"], "orig_sen": "Phenobarbital, which induces hepatic metabolism, decreased the AUC of montelukast approximately 40% following a single 10-mg dose of montelukast. ", "drug1": "Phenobarbital", "drug2": "montelukast"}, {"polarity": ["effect", "effect"], "orig_sen": "Catecholamine-depleting drugs (e.g., reserpine) may have an additive effect when given with beta-blocking agents. ", "drug1": "reserpine", "drug2": "beta-blocking agents"}, {"polarity": ["advise", "advise"], "orig_sen": "Aspirin should be used cautiously in conjunction with corticosteroids in patients suffering from hypoprothrombinemia. ", "drug1": "Aspirin", "drug2": "corticosteroids"}], "lose_item": [{"polarity": ["false"], "orig_sen": "CNS depressant medications: Concurrent use of procaine hydrochloride and CNS depressant medications may result in additive depressant effects. ", "drug1": "CNS depressant", "drug2": "CNS depressant medications"}, {"polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "HIV protease inhibitors", "drug2": "voriconazole"}, {"polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "HIV protease inhibitors", "drug2": "itraconazole"}, {"polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "HIV protease inhibitors", "drug2": "ketoconazole"}, {"polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "HIV protease inhibitors", "drug2": "azole antifungals"}, {"polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "HIV protease inhibitors", "drug2": "delavirdine"}, {"polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "HIV protease inhibitors", "drug2": "nelfinavir"}, {"polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "HIV protease inhibitors", "drug2": "indinavir"}, {"polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "HIV protease inhibitors", "drug2": "ritonavir"}, {"polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "HIV protease inhibitors", "drug2": "reverse transcriptase inhibitors"}, {"polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "clarithromycin", "drug2": "HIV protease inhibitors"}, {"polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "troleandomycin", "drug2": "HIV protease inhibitors"}, {"polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "erythromycin", "drug2": "HIV protease inhibitors"}, {"polarity": ["false"], "orig_sen": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). ", "drug1": "macrolide antibiotics", "drug2": "HIV protease inhibitors"}, {"polarity": ["false"], "orig_sen": "Potentiation occurs with ganglionic or peripheral adrenergic blocking drugs.", "drug1": "ganglionic adrenergic blocking drugs", "drug2": "peripheral adrenergic blocking drugs"}]}